Answers are grounded in this paper and cite their sources.
Neuropsychiatric disorders impact over 3 billion individuals globally, posing significant challenges due to their molecular complexity, phenotypic diversity, and limited clinical translation of genetic insights. Advances in induced pluripotent stem cell (iPSC) technology offer unprecedented opportunities to model these disorders in human-relevant contexts. Human iPSC-derived two-dimensional neurons and glia, and three-dimensional organoids recapitulate key aspects of brain development and cellular functions, enabling the study of disease mechanisms and therapeutic responses on the relevant genetic background. Pioneering studies have begun to demonstrate the potential of iPSC models for precision medicine. However, translating these findings to clinical applications at scale requires robust validity assessments. Building on established frameworks of construct, face, and predictive validity derived from animal models, this perspective examines their application within an iPSC context. These approaches offer valuable insights to refine iPSC-based modeling systems and enhance their translational relevance as well as address the complexities of modeling neuropsychiatric disorders.
No takes yet. Share an insight, caveat, or question.
Kolsters et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: